InsidersTradesSigma
Discover the detailed record of transactions filed by DiBiase Mary, Chief Operating Officer. Insider active across 1 companies, notably X4 Pharmaceuticals, Inc. Aggregated, 6 filings have been recorded. The latest transaction was disclosed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations
DiBiase Mary is the Chief Operating Officer at X4 Pharmaceuticals, Inc. She oversees the daily operations of the company, ensuring efficiency and implementation of operational strategies. Mary plays a key role in optimizing processes and managing resources, thereby contributing to the overall performance of the company. Her expertise in operational management is essential for the success of X4 Pharmaceuticals.